for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reuters Now

Bristol-Celgene deal could spur more pharma mergers

Posted

Bristol-Myers Squibb said on Thursday it would buy Celgene for about $74 billion, creating one of the biggest pharmaceutical companies and combining two significant cancer drug businesses.

Reuters Now

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up